Showing results (1-10 of 886) with videos related to
Sort By:
Pageof 89
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1984
Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancerF Labrie, A Dupont, A Bélanger, et al.The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experienceF Labrie, A Dupont, L Cusan, et al.Journal of Steroid Biochemistry|November 1, 1985
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survivalF Labrie, A Dupont, A Belanger, et al.Journal of Steroid Biochemistry|November 1, 1986
Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancerF Labrie, A Dupont, M Giguere, et al.British Journal of Urology|April 1, 1988
Benefits of combination therapy with flutamide in patients relapsing after castrationF Labrie, A Dupont, M Giguere, et al.Endocrine Reviews|February 1, 1986
Treatment of prostate cancer with gonadotropin-releasing hormone agonistsF Labrie, A Dupont, A Bélanger, et al.Progress in Clinical and Biological Research|January 1, 1988
Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancerF Labrie, A Dupont, M Giguère, et al.Journal of Steroid Biochemistry|January 1, 1987
Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patientsF Labrie, A Dupont, M Giguere, et al.European Journal of Cancer & Clinical Oncology|December 1, 1988
Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinomaF Labrie, A Dupont, M Giguere, et al.Journal of Steroid Biochemistry|October 1, 1989
Combination therapy with castration and flutamide: today's treatment of choice for prostate cancerF Labrie, A Dupont, L Cusan, et al.Pageof 89